E. Monteverde, a partner at Faruqi
& Faruqi, LLP, a leading national securities firm headquartered
in New York City, is investigating the Board of Directors of LIN Media
LLC ("LIN" or the "Company") (NYSE:LIN) for potential breaches of
fiduciary duties in connection with the sale of the Company to Media
General Inc. (MEG) for approximately $1.6 billion, or $2.6 billion
including debt of $968 million. The Company's stockholders will only
receive stock or cash worth $27.82, or 1.5762 shares of the Media
General Inc. for each share of LIN common stock they own. According to
Yahoo! Finance, at least one analyst estimated the target price to be
$32.00 per share.
Click here for more information: www.faruqilaw.com/LIN.
There is no cost or obligation to you.
The investigation focuses on whether LIN's Board of Directors breached
their fiduciary duties to the Company's stockholders by failing to
conduct a fair sales process and whether and by how much this proposed
transaction undervalues the Company to the detriment of LIN's
& Faruqi, LLP is a national law firm which represents investors
and individuals in class action litigation. The firm is focused on
providing exemplary legal services in complex litigation in the areas of
securities, shareholder, antitrust and consumer litigation, throughout
all phases of litigation. The firm has an experienced trial team which
has achieved significant victories on behalf of the firm's clients. To
keep track of the latest securities litigation news, follow us on
Twitter at www.twitter.com/MergerActivity
or on Facebook at www.facebook.com/FaruqiLaw.
If you own common stock in LIN and wish to obtain additional information
and protect your investments free of charge, please visit us at www.faruqilaw.com/LIN
or contact Juan E. Monteverde, Esq. either via e-mail at firstname.lastname@example.org
or by telephone at (877) 247-4292 or (212) 983-9330.
Attorney Advertising. (C) 2014 Faruqi & Faruqi, LLP. The law firm
responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).
Prior results do not guarantee or predict a similar outcome with respect
to any future matter. We are happy to discuss your particular case.
[ Back To NFVZone's Homepage ]